Compounds for imaging tau proteins that accumulate in brain

The present invention provides a compound represented by the following formula (I), a pharmaceutically acceptable salt thereof, or a solvate thereof:wherein:R1 and R2 are each separately selected from the group consisting of hydrogen, alkyl, alkenyl, acyl, and hydroxyalkyl;R3 is hydrogen or halogen;ring A is a benzene ring or a pyridine ring;ring B is selected from the group consisting of the following formulas (i), (ii), (iii), and (iv):in the formula (ii), Ra is alkyl;R4 and R5 are each separately selected from the group consisting of hydrogen, hydroxy, alkoxy, haloalkoxy, halohydroxyalkoxy, and aminoalkyl; andrepresents a double bond or a triple bond. The above compound can be used as a molecular probe for imaging tau proteins that accumulate in the brain..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 06. Juni Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

HIGUCHI MAKOTO [VerfasserIn]
SUHARA TETSUYA [VerfasserIn]
MARUYAMA MASAHIRO [VerfasserIn]
CHO MEIEI [VerfasserIn]
SHIMADA HITOSHI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
C07F: Acyclic, carbocyclic, or heterocyclic compounds con (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-06-06, Last update posted on www.tib.eu: 2023-07-05, Last updated: 2023-07-14

Patentnummer:

US11667628

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA01750256X